688526 科前生物
按盤價 
14.990 +1.490 (+11.037%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 4.017 | 10.799 | 12.316 | 19.473 | 23.400 |
| 總資產報酬率 ROA (%) | 3.339 | 8.738 | 10.092 | 16.698 | 19.981 |
| 投入資產回報率 ROIC (%) | 3.576 | 9.521 | 11.172 | 18.440 | 15.691 | 邊際利潤分析 |
| 銷售毛利率 (%) | 63.236 | 72.093 | 73.611 | 79.805 | 82.782 |
| 營業利潤率 (%) | 43.344 | 43.148 | 46.612 | 59.927 | 62.179 |
| 息稅前利潤/營業總收入 (%) | 35.621 | 36.768 | 40.267 | 53.972 | 57.765 |
| 淨利潤/營業總收入 (%) | 38.011 | 37.176 | 40.863 | 51.734 | 53.106 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 91.963 | 112.821 | 99.502 | 98.501 | 98.213 |
| 價值變動淨收益/利潤總額(%) | 5.858 | 2.041 | 1.735 | 0.777 | 0.766 |
| 營業外收支淨額/利潤總額(%) | -0.385 | -0.339 | -0.023 | -0.144 | -0.895 | 償債能力分析 |
| 流動比率 (X) | 4.144 | 3.384 | 4.105 | 3.578 | 6.950 |
| 速動比率 (X) | 3.929 | 3.193 | 3.834 | 3.357 | 6.750 |
| 資產負債率 (%) | 15.800 | 17.845 | 20.307 | 15.339 | 12.935 |
| 帶息債務/全部投入資本 (%) | 8.421 | 9.728 | 9.042 | 3.393 | -- |
| 股東權益/帶息債務 (%) | 1,063.171 | 910.127 | 970.482 | 2,777.643 | 3,102.180 |
| 股東權益/負債合計 (%) | 532.664 | 460.132 | 392.198 | 551.875 | 673.088 |
| 利息保障倍數 (X) | -4.714 | -5.897 | -6.356 | -9.197 | -14.956 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 141.383 | 110.821 | 106.339 | 68.653 | 0.000 |
| 存貨周轉天數 (天) | 170.194 | 190.461 | 189.534 | 145.359 | 0.000 |
| 備註： | 即時報價更新時間為 30/09/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
